… following the procedure. The trial, which was performed … potentially treatable causes of hypertension but often necessitate adrenal … mmHg without any antihypertensive medication. EUS-RFA was a … technique can transform the treatment of primary aldosteronism. …

… are now in the pharmaceutical development pipeline, one-third … after reports of pulmonary hypertension and heart-valve abnormalities … US Food and Drug Administration-Approved Drugs for Weight Loss … recognizes that anti-obesity medication and bariatric surgery …

… ocular hypertension,” said Malik Kahook, MD, co-founder of SpyGlass Pharma … off topical IOP-lowering medication at the 18-month … from its first-in-human trial, with plans to share … SpyGlass Drug Delivery Platform poised to reimagine the treatment paradigm …

Cardiovascular Rona Therapeutics Co. Ltd. has obtained IND clearance from China′s National Medical Products Administration (NMPA) for RN-1871, a small interfering RNA (siRNA) drug targeting angiotensinogen (AGT) for hypertension. BioWorld Science …

… ’s hypertension treatment is the latest medical device to earn the FDA’s … is currently conducting a clinical trial for its device in partnership … medication. The company has a strategic partnership with Medtronic for the development …

… treat [patients with] other diseases. The most common AEs observed included hypertension … to pause treatment or reduce the dose. In the trial, we started … ;www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-cabozantinib …

… it. Pharmacists like me are already highly trained in medication management, … by the American Pharmacists Association have found that pharmacy-based treatment for minor … hypertension. We have the education and experience to safely and effectively treat …

… medications versus placebo on dementia risk in patients with hypertension … dementia associated with antihypertensive treatment,” the researcher noted. … . “This randomized trial found that intensive blood … medications — can reduce someone’s risk of developing …

… Among patients with uncontrolled, treatment-resistant hypertension, aldosterone dysregulation is increasingly … , placebo-controlled Advance-HTN trial enrolled 285 patients currently on … of two to five antihypertensive medications with a blood-pressure …

… Co., accusing the New Jersey pharma’s subcutaneous Keytruda infringes 15 … Merck’s SC Keytruda is developed with a hyaluronidase from South … 3,000 bottles of OCD medication in the US after … dementia risk in patients with hypertension, large China trial reveals